Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
Kimberly N WeaverXian ZhangXiangfeng DaiRuna WatkinsJeremy AdlerMarla C DubinskyArthur KastlAthos BousvarosJennifer A StropleRaymond K CrossPeter D R HigginsRyan C UngaroMeenakshi BewtraEmanuelle BellaguardaFrancis A FarrayeMargie E BoccieriAnn FirestineMichael D KappelmanMillie D LongPublished in: Inflammatory bowel diseases (2021)
Our findings provide reassurance that the severe acute respiratory syndrome coronavirus 2 vaccine is safe and well tolerated among individuals with IBD, which may help to combat vaccine hesitancy and increase vaccine confidence.